US1053682035 - REIT

We assign a fundamental rating of **3** out of 10 to **BDN**. **BDN** was compared to 128 industry peers in the **Diversified REITs** industry. **BDN** has a bad profitability rating. Also its financial health evaluation is rather negative. **BDN** does not seem to be growing, but still is valued expensively. **BDN** also has an excellent dividend rating.

The **Average Return On Invested Capital** over the past 3 years for **BDN** is in line with the industry average of **2.99%**.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -0.27% | ||

ROE | -0.69% | ||

ROIC | 2.07% |

ROA(3y)3.17%

ROA(5y)2.73%

ROE(3y)7%

ROE(5y)6.09%

ROIC(3y)2.14%

ROIC(5y)2.23%

In the last couple of years the **Profit Margin** of **BDN** has declined.

Looking at the **Gross Margin**, with a value of **62.49%**, **BDN** is doing worse than **68.55%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 19.12% | ||

PM (TTM) | N/A | ||

GM | 62.49% |

OM growth 3Y0.23%

OM growth 5Y-0.79%

PM growth 3Y21.79%

PM growth 5Y-13.68%

GM growth 3Y0.31%

GM growth 5Y0.53%

There is no outstanding debt for **BDN**. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

Based on the Altman-Z score of **-0.18**, we must say that **BDN** is in the distress zone and has some risk of bankruptcy.

Looking at the **Altman-Z score**, with a value of **-0.18**, **BDN** is doing worse than **85.48%** of the companies in the same industry.

With a **Debt to FCF ratio** value of **78.76**, **BDN** perfoms like the industry average, outperforming **46.77%** of the companies in the same industry.

With a **Debt to Equity ratio** value of **1.42**, **BDN** is not doing good in the industry: **61.29%** of the companies in the same industry are doing better.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.42 | ||

Debt/FCF | 78.76 | ||

Altman-Z | -0.18 |

ROIC/WACC0.3

WACC6.8%

A Quick Ratio of **1.41** indicates that **BDN** should not have too much problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.41 | ||

Quick Ratio | 1.41 |

The earnings per share for **BDN** have been decreasing by **-13.76%** on average. This is quite bad

The **Revenue** has been growing slightly by **2.17%** in the past year.

The **Revenue** has been decreasing by **-0.56%** on average over the past years.

EPS 1Y (TTM)-141.18%

EPS 3Y17.73%

EPS 5Y-13.76%

EPS growth Q2Q-262.5%

Revenue 1Y (TTM)2.17%

Revenue growth 3Y-4.46%

Revenue growth 5Y-0.56%

Revenue growth Q2Q3.03%

The **Revenue** is expected to grow by **2.15%** on average over the next years.

EPS Next Y-197.74%

EPS Next 2Y-77.67%

EPS Next 3Y-46.94%

EPS Next 5YN/A

Revenue Next Year2.71%

Revenue Next 2Y4.03%

Revenue Next 3Y4.89%

Revenue Next 5Y2.15%

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

The **Price/Earnings Ratio** is negative for **BDN**. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the **Forward Price/Earnings Ratio** is negative for **BDN**. No positive earnings are expected for the next year.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A |

88.71% of the companies in the same industry are more expensive than **BDN**, based on the **Enterprise Value to EBITDA** ratio.

66.94% of the companies in the same industry are more expensive than **BDN**, based on the **Price/Free Cash Flow** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 26.55 | ||

EV/EBITDA | 9.85 |

A cheap valuation may be justified as **BDN**'s earnings are expected to decrease with **-46.94%** in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-77.67%

EPS Next 3Y-46.94%

Compared to an average industry **Dividend Yield** of **5.87**, **BDN** pays a better dividend. On top of this **BDN** pays more dividend than 97.58% of the companies listed in the same industry.

Compared to an average S&P500 **Dividend Yield** of **2.48**, **BDN** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 14.42% |

The dividend of **BDN** has a limited annual growth rate of **2.99%**.

Dividend Growth(5Y)2.99%

Div Incr Years0

Div Non Decr Years12

DP-1259.62%

EPS Next 2Y-77.67%

EPS Next 3Y-46.94%

**BRANDYWINE REALTY TRUST**

NYSE:BDN (2/22/2024, 3:15:00 PM)

After market: 4.18 0 (0%)**4.18**

**0 (0%) **

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap719.38M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 14.42% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -0.27% | ||

ROE | -0.69% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 19.12% | ||

PM (TTM) | N/A | ||

GM | 62.49% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.13

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.42 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.41 | ||

Quick Ratio | 1.41 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-141.18%

EPS 3Y17.73%

EPS 5Y

EPS growth Q2Q

EPS Next Y-197.74%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)2.17%

Revenue growth 3Y-4.46%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y